Filter By Industry
Filter By Tag

Newsroom

Van Andel Institute Press releases

1 - 10 of 35 Press Releases

Jun 27, 2012
Van Andel Institute announces that researchers at Lund University in Sweden have published a study detailing how Parkinson's disease spreads through the brain. The breakthrough brings researchers closer to a disease-modifying drug for Parkinson's.

May 29, 2012
Researchers from South Korea, Sweden, and the United States have collaborated on a project to restore neuron function to parts of the brain damaged by Huntington’s disease by transplanting HD-induced pluripotent stem cells into animal models.

May 16, 2012
Van Andel Research Institute (VARI) and Dako, the Danish-based, worldwide supplier of cancer diagnostic tools today announce an agreement to license, manufacture and distribute cancer diagnostics utilizing the MET4 Antibody.

May 14, 2012
A team of scientists has made a breakthrough in a deadly type of liver cancer. By identifying new genes frequently mutated in bile duct cancers, researchers are paving the way for better understanding of how bile duct cancers develop.

Jan 31, 2012
A new study reveals substantial differences – by both surgeon and institution – in the rates of follow-up surgeries for women who underwent a partial mastectomy for treatment of breast cancer.

Jan 23, 2012
A recent Van Andel Research Institute study published in the journal Science investigating molecular structure & function of a plant hormone could change our understanding of a key cell process & lead to new drug development for various diseases.

Dec 29, 2011
Two recent studies distinguish cancer subtypes and provide promising new drug targets

Nov 21, 2011
Study reveals a natural fatty acid used in manufacturing can modulate glucose control

Jul 29, 2011
Michigan State University’s College of Human Medicine and Van Andel Research Institute / TGen partner to investigate drug that could halt progression of Parkinson’s disease

Jul 18, 2011
Van Andel Research Institute scientists have uncovered how the anti-malaria drug chloroquine represses inflammation, and may provide a blueprint for new strategies for treating inflammation and a multitude of autoimmune diseases.


Page: 1 2 3 4 Next
Van Andel Institute RSS Feed